Product Images Arformoterol Tartrate Inhalation
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 10 images provide visual information about the product associated with Arformoterol Tartrate Inhalation NDC 70436-151 by Slate Run Pharmaceuticals, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This is a table that includes data for a clinical trial of a drug called arformoterol tartrate inhalation solution. The drug is being tested to see if it improves FEV (forced expiratory volume) in patients. The table shows the hours post-dose along the top and the number of participants in the trial on the left-hand side. The baseline FEV for each group is also provided in liters (L). It appears that the group receiving the 15 mcg dose of arformoterol tartrate inhalation solution twice a day had a slightly lower baseline FEV than the placebo group.*
The text provides data on the mean change from baseline FEV in two groups- Placebo (n=143) and 15 mcg arformoterol tartrate inhalation solution BID (n=141). The measure was taken in Hours Postdose. The baseline FEV was 1.20(L) for Placebo and 1.15(L) for the arformoterol group.*
This is a description of a medication called SR Dot which contains Arformoterol Tartrate Inhalation Solution. It is to be kept refrigerated or stored at room temperature for up to 6 weeks. The medication is meant only for oral inhalation.*
This text only says "FACE MASK". It is a limited text and does not provide any useful information about face masks.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.